The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer
Abstract
Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past few years. It is widely explored in drug delivery, where the development of nanomedicines for cancer, one of the major public health concerns nowadays, has not been the exception. As a biocompatible, biodegradable and bioresorbable polymer, PCL has also found plenty of uses in the form of microparticles and scaffolds; so is the main objective of the present review to emphasize its potential and present its properties along with applications in the pharmaceutical and biomedical area with a special focus on nanomedicine in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Biodegradable polymers as biomaterials
Nair, L. S., & Laurencin, C. T. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.017 · Cited by 4,416
The return of a forgotten polymer—Polycaprolactone in the 21st century
Woodruff, M. A., & Hutmacher, D. W. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.002 · Cited by 4,033 · cited 6×
“Despite great attention was focused on PCL in the past, its use as a biocompatible and biodegradable polymer failed due to the arrival of faster degradable polymers like polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) during the last decades([3]).”
BackgroundInfluentialBiomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206 · cited 1×
“For many years, the main impediment for the complete successful application of PCL in nanoparticulated drug delivery system has been the idea of its low degradation rate([36]), even though the degradation behavior of PCL was mostly established using “bulk” implants for in vivo models.”
BackgroundDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712 · cited 1×
“For nasopharyngeal carcinoma treatment, TPGS-PCL-ranPGA loaded with siRNA for targeting HIF-1a (hypoxiainducible factor 1a, closely related to cancer progression([274])) showed improved cytotoxic activity on CNE-2 cells (problematic cell line, originally thought to originate from a nasopha-”
Doxorubicin: The good, the bad and the ugly effect
Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803312 · Cited by 1,509
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278 · cited 1×
“Other approaches used a mixture of PCL and PluronicVR F-68 to treat breast cancer cells exhibiting multidrug resistance since it was demonstrated that poloxamers are capable to drastically sensitize these cells to anti-neoplastic drugs([182,183]).”
MethodTransport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · cited 1×
“This ability was explained, most probably, to occur due to apolipoprotein-E accumulation on polysorbate 80-coated nanoparticles, allowing nanoparticle receptormediated endocytosis through the BBB endothelial cells since apolipoprotein-E is a specific ligand to LRP receptors, which, as was mentioned, are abundant in th…”
BackgroundRing-Opening Polymerization—An Introductory Review
Nuyken, O., & Pask, S. (2013) · Polymers · doi:10.3390/polym5020361 · Cited by 456 · cited 4×
“perature have important effects on the microstructure of the products([71]).”
BackgroundMethodInfluentialEffects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheres
Jeong, J.-C., Lee, J., & Cho, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00367-5 · Cited by 209 · cited 1×
“Doxycycline Emulsion-solvent evaporation [95] Recombinant malaria antigen Thin-film hydration [96] Papaverine Emulsion-solvent evaporation [97] Felodipine Emulsion-solvent evaporation [98] Quenching Bovine serum albumin Double emulsion-solvent evaporation [99,100]”
MethodKanazawa, T., Taki, H., Tanaka, K., Takashima, Y., & Okada, H. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0440-7 · Cited by 166 · cited 1×
“trating peptide capable to promote intranasal drug transport to the brain([153]), to deliver camptothecin for the treatment of gliomas.”
BackgroundWu, Y., Zhang, Y., Zhang, W., Sun, C., Wu, J., & Tang, J. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.11.041 · Cited by 100
Tang, Z., Zhang, L., Wang, Y., Li, D., Zhong, Z., & Zhou, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.038 · Cited by 73 · cited 2×
“lung PCL-g-chondroitin sulfate doxorubicin [209] lung thiolated chitosan/PLA-PCL-TPGS paclitaxel [210] lung MPEG-PCL curcumin/doxorubicin [218] lung PVP-PCL tetrandrine [212] lung MPEG-PCL curcumin [213–215] lung PVP-PCL curcumin [216] lung MPEG-PCL fisetin [217] lung PCL-PEG-PCL SPION/curcumin/silibinin [222] lung HS…”
BackgroundSynthetic biodegradable medical polyesters
Cama, G., Mogosanu, D. E., Houben, A., & Dubruel, P. (2017) · Science and Principles of Biodegradable and Bioresorbable Medical Polymers · doi:10.1016/b978-0-08-100372-5.00003-9 · Cited by 33
Cited by
Biopolymer: A Sustainable Material for Food and Medical Applications
Baranwal, J., Barse, B., Fais, A., Delogu, G. L., & Kumar, A. (2022) · Polymers · doi:10.3390/polym14050983 · Cited by 727
Kuperkar, K., Patel, D., Atanase, L. I., & Bahadur, P. (2022) · Polymers · doi:10.3390/polym14214702 · Cited by 333
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
Su, S., & Kang, P. M. (2020) · Nanomaterials · doi:10.3390/nano10040656 · Cited by 312
Dalton, M., Ebrahimi, F., Xu, H., Gong, K., Fehrenbach, G., Fuenmayor, E., Murphy, E. J., & Major, I. (2023) · Macromol · doi:10.3390/macromol3030026 · Cited by 28
Metadata
- Authors
- Espinoza, S. M., Patil, H. I., San Martin Martinez, E., Casañas Pimentel, R., & Ige, P. P.
- Venue
- International Journal of Polymeric Materials and Polymeric Biomaterials
- Publisher
- Informa UK Limited
- Published
- 2019-02-08
- Volume
- 69
- Issue
- 2
- Pages
- 85-126
- ISSN
- 0091-4037 (ISSN-L)
- 1563-535X
- OpenAlex
- W2911341288
- Cited by
- 162
- References
- 15
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.